Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.

NJ, Bundred; ID, Campbell; N, Davidson; RH, DeBoer; H, Eidtmann; A, Monnier; P, Neven; Minckwitz G, von; JC, Miller; NL, Schenk; RE, Coleman

doi:10.1002/cncr.23259

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. | NobleBlocks